Agilent Technologies, Inc. stock is up 16.46% since 30 days ago. The dividend yield is 0.85% and its next earnings date is Feb 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 24 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 7 PUTs, 3 CALLs. 75% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
21 Nov 20:46 | 19 Jan, 2024 | 125.00 | 137 | ||
22 Nov 19:57 | 19 Jan, 2024 | 120.00 | 477 | ||
27 Nov 14:56 | 17 Jan, 2025 | 125.00 | 73 | ||
29 Nov 19:44 | 19 Jan, 2024 | 150.00 | 18 | ||
30 Nov 15:32 | 17 Jan, 2025 | 125.00 | 128 | ||
30 Nov 16:08 | 16 Feb, 2024 | 140.00 | 0 | ||
01 Dec 17:59 | 17 Jan, 2025 | 125.00 | 376 | ||
01 Dec 18:52 | 19 Jan, 2024 | 125.00 | 269 | ||
04 Dec 15:40 | 17 Jan, 2025 | 125.00 | 173 | ||
05 Dec 16:37 | 19 Jan, 2024 | 130.00 | 153 |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, and genetic data management.